We provide you with 20 years of free, institutional-grade data for CELC stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of CELC. Explore the full financial landscape of CELC stock.
Total insider purchase within 3 month on this page: $9,563,022
Total insider selling within 3 month on this page: -$4,743,439
| Name | Action | Shares | Avg Price | Amount | Reported Date |
|---|---|---|---|---|---|
| BAKER BROS. ADVISORS LP | Open Market Purchase | 155,736 | $56.22 | 2025-09-10 | |
| BAKER BROS. ADVISORS LP | Open Market Purchase | 14,364 | $56.22 | 2025-09-10 | |
| Dalvey David | Sale | -100,000 | $43.3 | $4,329,740 | 2025-07-30 |
| Dalvey David | Sale | -9,325 | $44.36 | $413,700 | 2025-07-30 |
| Buller Richard E | Grant, award...etc | 1,029 | 2025-05-21 | ||
| Furcht Leo | Derivatives Exercise | 250 | 2024-12-03 | ||
| Buller Richard E | Sale | -350 | $16.25 | $5,688 | 2024-10-25 |
| Buller Richard E | Sale | -350 | $16.95 | $5,933 | 2024-08-27 |
| Buller Richard E | Sale | -350 | $15.68 | $5,488 | 2024-06-25 |
| Buller Richard E | Grant, award...etc | 1,079 | 2024-06-06 | ||
| Buller Richard E | Sale | -350 | $17.06 | $5,971 | 2024-04-26 |
| Buller Richard E | Sale | -350 | $14.15 | $4,953 | 2024-02-23 |
| Buller Richard E | Sale | -350 | $14.37 | $5,030 | 2023-12-22 |
| Dalvey David | Sale | -7,940 | $14.75 | $117,117 | 2023-12-18 |
| Dalvey David | Sale | -7,060 | $14.61 | $103,121 | 2023-12-14 |
| Dalvey David | Sale | -10,000 | $14.85 | $148,500 | 2023-12-11 |
| Furcht Leo | Derivatives Exercise | 250 | 2023-11-30 | ||
| Buller Richard E | Sale | -350 | $10.23 | $3,581 | 2023-10-27 |
| Buller Richard E | Sale | -350 | $9.28 | $3,248 | 2023-09-01 |
| Buller Richard E | Sale | -300 | $9.82 | $2,946 | 2023-08-25 |
| Buller Richard E | Sale | -300 | $11.79 | $3,537 | 2023-06-27 |
| Buller Richard E | Sale | -75 | $11.1 | $833 | 2023-05-25 |
| Furcht Leo | Open Market Purchase | 10,000 | $10.32 | 2023-05-24 | |
| Buller Richard E | Sale | -350 | $9.85 | $3,448 | 2023-05-23 |
| Buller Richard E | Grant, award...etc | 1,958 | 2023-05-17 | ||
| Buller Richard E | Sale | -300 | $9.7 | $2,910 | 2023-04-25 |
| Buller Richard E | Sale | -300 | $11.4 | $3,420 | 2023-02-23 |
The information provided in this report about CELC stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Celcuity Inc(NASDAQ:CELC) 
Celcuity Inc., a clinical stage biotechnology company, discovers cancer sub-types and therapeutic options for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's c...
Website: http://www.celcuity.com
Founded: 2011
Full Time Employees: 27
Founder: Brian Sullivan / Lance Laing
CEO: Brian Sullivan
Sector: Healthcare
Industry: Diagnostics & Research